Eledon Pharmaceuticals (ELDN) Change in Accured Expenses (2013 - 2022)

Eledon Pharmaceuticals' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at $210000.0 for Q4 2022.

• Quarterly Change in Accured Expenses rose 28.83% year-over-year to $210000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $2.1 million (down 2.89% YoY) and the FY2022 annual result came in at $2.1 million, down 2.89% from the prior year.
• Change in Accured Expenses was $210000.0 for Q4 2022 at Eledon Pharmaceuticals, down from $2.9 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $4.2 million in Q3 2020 and bottomed at -$4.0 million in Q4 2020.
• A 5-year average of $194350.0 and a median of $171000.0 in 2018 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 1558.42% in 2020, while the deepest fall reached 1084.21% in 2020.
• Eledon Pharmaceuticals' Change in Accured Expenses stood at $931000.0 in 2018, then plunged by 136.73% to -$342000.0 in 2019, then sank by 1084.21% to -$4.0 million in 2020, then surged by 104.02% to $163000.0 in 2021, then rose by 28.83% to $210000.0 in 2022.
• Business Quant data shows ELDN's Change in Accured Expenses at $210000.0 in Q4 2022, $2.9 million in Q3 2022, and $359000.0 in Q2 2022.